![](https://www.genomes2people.org/wp-content/uploads/2018/08/20180501_ClinicalOmics.png)
A study of two groups of 100 patients found no evidence that whole genome sequencing increases downstream healthcare costs. The story begins on Page 12.
A study of two groups of 100 patients found no evidence that whole genome sequencing increases downstream healthcare costs. The story begins on Page 12.